Synergy, Additive Effects, and Antagonism of Drugs with Plant Bioactive Compounds
Drugs and Drug Candidates · 05.02.2025 · 4 (1) · 4
DOI: 10.3390/ddc4010004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drugs and Drug Candidates, online erschienen am 05.02.2025. Verfasst von Noureddine Chaachouay. Die Arbeit wurde bisher 130-mal zitiert (Crossref) und nennt 207 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: The interaction of bioactive compounds derived from plants with drugs has become a significant area of investigation due to its potential to improve, reduce, or have no effect on therapeutic outcomes. Due to the dual effect of these interactions, elucidating the underlying mechanisms is essential for establishing a therapeutic strategy. This study emphasizes the significant findings, mechanisms, and clinical implications of drug–plant bioactive interactions. It calls for more studies to seek safe and effective incorporation into clinical practice.
Methods
To identify relevant studies, we performed a systematic literature search based on various scientific databases from 11 August 2024 to 30 December 2024. The search will be based on relevant keywords such as synergy, antagonism, plant bioactive compounds, and drug interactions supplemented with secondary terms such as phytochemicals, herb-drug interactions, pharmacokinetics, and pharmacodynamics.
Results
Plant bioactives, including polyphenols, flavonoids, alkaloids, and terpenoids, display valuable biological activities that can interact with medications in three principal ways: synergy, additive effects, and antagonism. Synergy occurs when the combined effects of plant chemicals and pharmaceuticals outweigh the sum of their separate effects, increasing therapeutic effectiveness or allowing dosage decrease to reduce adverse effects. Additive effects occur when the combined impact equals the total individual effects, resulting in better outcomes without increasing risk. Antagonism occurs when a plant ingredient reduces or counteracts the effects of a medicine, thereby jeopardizing treatment. In addition, specific interactions may have no discernible effect. The chemical makeup of bioactive chemicals, medication pharmacokinetics, and individual patient characteristics such as genetics and metabolism all impact the intricacy of these interactions.
Conclusions
Pharmacokinetics and pharmacodynamics of drugs can be considerably modulated through their interactions with plant bioactive components, which may cause a significant decrease in efficacy or increase in toxicity of therapeutic agents. More studies are needed to clarify mechanisms of action, prove clinical relevance, and create guidelines for safe co-administration. This integrative approach can mitigate those risks and allow for therapeutic optimization by introducing pharmacogenomics and personalized medicine approaches.
Zitieren
APA
Chaachouay, N. (2025). Synergy, Additive Effects, and Antagonism of Drugs with Plant Bioactive Compounds. Drugs and Drug Candidates, 4(1), 4. https://doi.org/10.3390/ddc4010004
Vancouver
Chaachouay N. Synergy, Additive Effects, and Antagonism of Drugs with Plant Bioactive Compounds. Drugs and Drug Candidates. 2025;4(1):4. doi:10.3390/ddc4010004
BibTeX
@article{Chaachouay2025,
author = {Chaachouay, Noureddine},
title = {Synergy, Additive Effects, and Antagonism of Drugs with Plant Bioactive Compounds},
journal = {Drugs and Drug Candidates},
year = {2025},
volume = {4},
number = {1},
pages = {4},
doi = {10.3390/ddc4010004}
}
EUVIMED